Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting
2014-12-09 09:30
Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma
2014-12-09 09:30
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS(R) (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
2014-12-09 09:30
Daiichi Sankyo Launches New Formulation of LIXIANA(R) 60 mg Tablets (edoxaban) in Japan
2014-12-08 21:19
Pyunkang Korean Medicine Hospital: The Great Vision of a Doctor of Korean Medicine Banning Chemical Medicines
2014-12-05 22:00
Takeda's Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis
2014-12-05 09:30
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
2014-12-05 00:53
PneumRx Acquired by BTG plc for up to $475 Million
2014-12-04 15:30
Merck Serono Awards Grant for Growth - Countdown for Accepting Applications
2014-12-04 15:30
China Bolsters International Response to Ebola with USD $6 Million Donation
2014-12-02 18:38
International College of Neuropsychopharmacology (CINP) Calls on Governments to Reverse 'Disturbing' Trend of Lack of New Drugs for the 10% of the Global Population Affected by Brain Diseases
2014-12-01 20:00
DKSH Hong Kong expands cold chain capacity
2014-12-01 14:00
CareNet Joins the Indegene Partnership Network to Accelerate Growth in Japanese Markets
2014-11-27 09:00
Asia is the Key Growth Region for FDI, Finds Frost & Sullivan
2014-11-26 21:22
European Commission Approves Trulicity® (dulaglutide) Solution for Injection, Lilly's Once-Weekly, Ready-to-Use Type 2 Diabetes Treatment
2014-11-25 16:30
AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia
2014-11-21 10:00
Frost & Sullivan Honors Codonics for Enhancing Patient Safety and Accuracy of Medication Management with the Safe Label System (SLS)
2014-11-20 21:00
Amgen Opens Next-generation Biomanufacturing Facility in Singapore
2014-11-20 11:00
DKSH to provide Market Expansion Services to Minsheng in China
2014-11-18 14:00
BioPh China 2015 Gears Up as the Best Platform for Branding, Trading and Barnstorming
2014-11-13 09:00
1
163
164
165
166
167
170